A controlled clinical trial evaluated the anti-inflammatory and antioxidative effects of OEA (250 mg/day) on obesity, as well as assessing LPO, TAC, CRP, IL-6, and TNF-α levels. This evidence concerns the gene CRP and obesity disorder.